Advertisement

Erkrankungen der Speiseröhre

  • T. Sauerbruch
  • J. E. Dominguez-Munoz

Abstract

Die erkrankte Speiseröhre reagiert mit verschiedenen Symptomen: Sodbrennen (ein meist postprandial auftretender brennender Schmerz zwischen Epigastrium und Rachen), Odynophagie (die schmerzhafte Passage eines Bissens), krampfartige Schmerzen (häufig in den Rücken ausstrahlend) und Dysphagie (das Gefühl des Steckenbleibens der Nahrung).

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Anderson KD, Rouse TM, Randolph JG (1990), A controlled trial of corticosteroids in children with corrosive injury of the esophagus. N Engl J Med 323:637–640PubMedCrossRefGoogle Scholar
  2. 2.
    Angelini G, Fratta Pasini A, Ederle A, Castagnini A, Talmini G, Bulighin G (1991) Nd: YAG laser versus polidocanol injection for palliation of esophageal malignancy: a prospective, randomized study. Gastrointest Endosc 37:607–610PubMedCrossRefGoogle Scholar
  3. 3.
    Barradell LB, Faulds D, McTavish D (1992). Lanzoprazole: a review of its pharmacodynamic and pharmacokinetic properties and its therapeutic efficacy in acid related disorders. Drugs 44:225–250PubMedCrossRefGoogle Scholar
  4. 4.
    Binmoeller KF, Maeda M, Liebermann D, Katon RM, Ivancev K, Rosch J (1992). Siliconecovered expandable metallic stents in the esophagus: an experimental study. Endoscopy 24:416–420PubMedCrossRefGoogle Scholar
  5. 5.
    Buset M, des Marez B, Baize M et al. (1987). Palliative endoscopic management of obstructive esophagogastric cancer: laser or prosthesis? Gastrointest Endosc 33:357–361PubMedCrossRefGoogle Scholar
  6. 6.
    Castell DO, Dalton CB, Becker D, Sinclair J, Castell JA (1992). Alginic acid decreases postprandial upright gastroesophageal reflux. Comparison with equal strength antacid. Dig Dis Sci 37:589–593PubMedCrossRefGoogle Scholar
  7. 7.
    Coccia G, Bortolotti M, Michetti P et al (1991). Prospective clinical and manometric study comparing pneumatic dilatation and sublingual nifedipine in the treatment of esophageal achalasia. Gut 32:604–606PubMedCrossRefGoogle Scholar
  8. 8.
    Csendes A, Braguetto I, Henriquez A, Cortes C (1989). Late results of a prospective randomized study comparing forceful dilatation and oesophagomyotomy in patients with achalasia. Gut 30:299–304PubMedCrossRefGoogle Scholar
  9. 9.
    Eckardt VF, Aignherr C, Bernhard G (1992). Predictors and outcome in patients with achalasia treated by pneumatic dilation. Gastroenterology 103:1732–1738PubMedGoogle Scholar
  10. 10.
    Eng J, Sabanathan S (1991). Drug-induced esophagitis. Am J Gastroenterol 86:1127–1133PubMedGoogle Scholar
  11. 11.
    Galmiche JP, Fraitag B, Filoche B et al (1990). Double-blind comparison of cisapride and Cimetidine in treatment of reflux esophagitis. Dig Dis Sci 35:649–655PubMedCrossRefGoogle Scholar
  12. 12.
    Gasparri G, Casalegno PA, Camandona M et al (1987). Endoscopic insertion of 248 prostheses in inoperable carcinoma of the esophagus and cardia: short-therm and long-term results. Gastrointest Endosc 33:354–356PubMedCrossRefGoogle Scholar
  13. 13.
    Gelfond M, Rosen P, Gilat T (1982). Isosorbide dinitrate and nifedipine treatment of achalasia: a clinical, manometric and radionuclide evaluation. Gastroenterology; 83: 963–969PubMedGoogle Scholar
  14. 14.
    Grégoire J, Duranceau A (1991). Surgical management of Zenker’s diverticulum. Hepatogastroenterology 39:132–138Google Scholar
  15. 15.
    Groskreutz JL, Kim CH (1990). Schatzki’s ring: long-term results following dilation. Gastrointest Endosc 36:479–481PubMedCrossRefGoogle Scholar
  16. 16.
    Herskovic A, Martz K, Al-Sarraf M et al (1992). Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 326:1593–1598PubMedCrossRefGoogle Scholar
  17. 17.
    Hetzel DJ, Dent J, Reed WD et al (1988). Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology 95:903–912PubMedGoogle Scholar
  18. 18.
    Hill LD, Mercer CD (1988). Rings, webs, and diverticula. In: Hill LD, Kozarek R, McCallum R, Mercer CD, eds. The esophagus: medical and surgical management. Saunders Philadelphia pp 132–138Google Scholar
  19. 19.
    Holt S, Howden CW (1991). Omeprazole: overview and opinion. Dig Dis Sci 36:385–393PubMedCrossRefGoogle Scholar
  20. 20.
    Irving JD, Owen WJ, Linsell J, McCullagh M, Keightley A, Anggiansah A (1992). Management of diffuse esophageal spasm with balloon dilatation. Gastrointest Radiol 17: 189–192PubMedCrossRefGoogle Scholar
  21. 21.
    Kadakia SC, Wong RKH (1993). Graded pneumatic dilation using Rigiflex achalasia dilators in patients with primary esophageal achalasia. Am J Gastroenterol 88:34–38PubMedGoogle Scholar
  22. 22.
    Kikendall JW (1990). Caustic injury of the esophagus and stomach. In: Bayless TM, ed. Current therapy in gastroenterology and liver disease. 3. Decker Toronto pp 22–26Google Scholar
  23. 23.
    Klinkenberg-Knol EC (1992). The role of omeprazole in healing and prevention of reflux disease. Hepatogastro-enterol 39:27–30Google Scholar
  24. 24.
    Koop H, Arnold R (1991). Long-term maintenance treatment of reflux esophagitis with omeprazole: prospective study in patients with H2-blocker-resistant esophagitis. Dig Dis Sci 36:552–557PubMedCrossRefGoogle Scholar
  25. 25.
    Laine L, Dretler RH, Conteas CN et al (1992). Fluconazole compared with ketoconazole for the treatment of candida esophagitis in AIDS: a randomized trial. Ann Intern Med 117:655–660PubMedCrossRefGoogle Scholar
  26. 26.
    Lambert R (1992). Endoscopic therapy of esophago-gastric tumors. Endoscopy 24:24–33PubMedCrossRefGoogle Scholar
  27. 27.
    Levine DS, Haggitt RC, Blount PL, Rabinovitch PS, Rusch VW, Reid BJ (1993). An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett’s esophagus. Gastroenterology 105: 40–50PubMedGoogle Scholar
  28. 28.
    Mendelsohn M (1993). New concepts in dysphagia management. J Otolaryngol 22 [Suppl 1]: 1–24PubMedGoogle Scholar
  29. 29.
    Müller JM, Erasmi H, Stelzner M, Zieren U, Pichlmaier H (1990). Surgical therapy of oesophageal carcinoma. Br J Surg 771:845–857CrossRefGoogle Scholar
  30. 30.
    Nelson JB, Richter JE (1989). Upper esophageal motility disorders. Gastroenterol Clin North Am 18:195–222PubMedGoogle Scholar
  31. 31.
    Renwick P, Whitton V, Moghissi K (1992). Combined endoscopic laser therapy and bradytherapy for palliation of esophageal carcinoma: a pilot study. Gut 33:435–438PubMedCrossRefGoogle Scholar
  32. 32.
    Robinson M, Maton PN, Allen ML et al (1991). Effect of different doses of omeprazole on 24-hr oesophageal acid exposure in patients with gastroesophageal reflux. Aliment Pharmacol Ther 5:645–661PubMedCrossRefGoogle Scholar
  33. 33.
    Rufail W, Belsito A, Robinson M, Barish C, Rubin A, Glaxo Erosive Study Group (1992). Ranitidine for erosive oesophagitis: a double-blind, placebo-controlled study. Aliment Pharmacol Ther 6:597–607CrossRefGoogle Scholar
  34. 34.
    Shimi SM, Nathanson LK, Cuschieri A (1992). Thoracoscopc long oesophageal myotomy for nutcracker esophagus: initial experience of a new surgical approach. Br J Surg 79:533–536PubMedCrossRefGoogle Scholar
  35. 35.
    Short TP, Thomas E (1992). An overview of the role of calcium antagonists in the treatment of achalasia and diffuse esophageal spasm. Drugs 43:177–184PubMedCrossRefGoogle Scholar
  36. 36.
    Siewert JR, Dittler HJ (1993). Esophageal carcinoma: impact of staging on treatment. Endoscopy 25:28–32PubMedCrossRefGoogle Scholar
  37. 37.
    Siewert JR, Roder JD, Fink U (1990). Fortschritte in der chirurgischen Behandlung des Plattenepithelkarzinoms der Speiseröhre. Internist 31:131–142PubMedGoogle Scholar
  38. 38.
    Simon D, Weiss LM, Brandt LJ (1992). Treatment options for AIDS-related esophageal and diarrheal disorders. Am J Gastroenterol 87:274–281PubMedGoogle Scholar
  39. 39.
    Sontag SJ, Hirschowitz BI, Holt S et al. (1992). Two doses of Omeprazol versus placebo in symptomatic erosive eso-phagitis: the U.S. multicenter study. Gastroenterology 102: 109–118PubMedGoogle Scholar
  40. 40.
    Spechler SJ, Deparment of Veterans Affairs Gastroesophageal Reflux Disease Study Group (1992). Comparison of medical and surgial therapy for complicated gastroesophageal reflux disease in veterans. N Engl J Med 326:786–792PubMedCrossRefGoogle Scholar
  41. 41.
    Stalnikowicz-Darvasi R (1989). H2-antagonists in the treatment of reflux esophagitis: a critical analysis. Am J Gastroenterol 84:245–248PubMedGoogle Scholar
  42. 42.
    Stein HJ, Siewert JR (1993). Endobrachyösophagus: Pathogenese, Epidemiologie and maligne Degeneration. Dtsch med Wschr 118:511–519PubMedCrossRefGoogle Scholar
  43. 43.
    Tilanus HW, Bossuyt P, Schattenkerk ME, Obertop H (1991). Treatment of oesophageal perforation: a multivariate analysis. Br J Surg 78:582–585PubMedCrossRefGoogle Scholar
  44. 44.
    Timmer R, Breumelhof R, Nadorp J, Smout A (1993). Recent advances in the pathophysiology of gastro-esophageal reflux disease. Eur J Gastroenterol Hepatol 5:485–491Google Scholar
  45. 45.
    Toussaint J, Gossuin A, Deruyttere M, Hublé F, Devis G (1991). Healing and prevention of relapse of reflux oesophagitis by cisapride. Gut 32:1280–1285PubMedCrossRefGoogle Scholar
  46. 46.
    Tytgat GNJ, Nicolai JJ, Reman FC (1990). Efficacy of different doses of Cimetidine in the treatment of reflux esophagitis: a review of three large, double-blind, controlled trials. Gastroenterology 99:629–634PubMedGoogle Scholar
  47. 47.
    Tytgat GNJ, Anker Hansen OJ, Carling L et al (1992). Effect of cisapride on relapse of reflux esophagitis healed with an antisecretory drug. Scand J Gastroenterol 27:81–84PubMedCrossRefGoogle Scholar
  48. 48.
    Vermeijden JR, Tytgat GNJ, Schotborgh RH et al (1992). Combination therapy of sucralfate and ranitidine, compared with sucralfate monotherapy in patients with peptic reflux esophagitis. Scand J Gastroenterol 27:81–84PubMedCrossRefGoogle Scholar
  49. 49.
    Wienbeck M, Berges W (1984) Funktionelle Erkrankungen der Speiseröhre:Achalasie, Spasmen, sekundäre Störungen. In: Demling L, Domschke S (eds) Klinische Gastroenterologie. Thieme Stuttgart S 254–265Google Scholar
  50. 50.
    Wilcox CM (1992) Esophageal disease in the acquired immunodeficiency syndrome: etiology, diagnosis and management. Am J Med 92:412–421PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1995

Authors and Affiliations

  • T. Sauerbruch
  • J. E. Dominguez-Munoz

There are no affiliations available

Personalised recommendations